Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology.
about
Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-DistancePharmacodynamic imaging guides dosing of a selective estrogen receptor degraderTissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine.
P2860
Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparing duration of response ...... pplication of new methodology.
@ast
Comparing duration of response ...... pplication of new methodology.
@en
type
label
Comparing duration of response ...... pplication of new methodology.
@ast
Comparing duration of response ...... pplication of new methodology.
@en
prefLabel
Comparing duration of response ...... pplication of new methodology.
@ast
Comparing duration of response ...... pplication of new methodology.
@en
P2093
P2860
P50
P1476
Comparing duration of response ...... application of new methodology
@en
P2093
Didier Verhoeven
Guy Jerusalem
Iva Smirnova
José L Pedrini
Kelly Pendergrass
Mikhail R Lichinitser
Roberto Torres
Sally Anne Garnett
P2860
P2888
P304
P356
10.1007/S10549-012-2395-8
P407
P577
2013-02-03T00:00:00Z